PLSE Pulse Biosciences Inc gains 37% Feb 12, 2021

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It engages in the research and development, and commercialization of CellFX system that provides a precise and non-thermal cellular treatment technology delivering nanosecond duration energy pulses that impact cells in treated tissue while sparing surrounding non-cellular tissue primarily for dermatology applications. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was founded in 2014 and is headquartered in Hayward, California.http://www.priceseries.com/trade/PLSE-Pulse-Biosciences-Inc-stock-gains-37-percent-a-Trade-Record-by-priceSeries-2021011520210212.html